Fierce Biotech's Fundraising Tracker lists venture capital rounds of $50 million or more secured by biotechnology companies.
Longevity News
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
Source: FierceBiotech - All • Published: 19 Feb 2026, 22:00
Continue exploring
Related longevity signals
Longevity TechnologyLongevica appoints ex-Genentech biotech veteran as CEOLongevica names a new CEO as it pivots toward preclinical drug development; read an update on leadership and strategic direction.Longevity TechnologyUtah is building America’s longevity capitalA look at how a regional mix of clinics, consumer brands, and wellness tech is turning Utah into a practical longevity economy.Lifespan.ioA Million-Person Study Finds a Protective Metabolic GeneHuman genetics research exploring metabolic regulation and disease risk, previewing an article that examines gene-based discoveries and potential therapeutic pathways.PR NewswireAureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug DiscoveryA biotech funding story about a startup scaling AI-native drug discovery and building biological foundation models; a look at its R&D strategy and platform.
